Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
Condition:   Type 1 Diabetes Intervention:   Drug: Insulin Glargine 300 UNT/ML [Toujeo] Sponsors:   prof dr Pieter Gillard;   University Hospital, Antwerp;   Onze Lieve Vrouw Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2021 Category: Research Source Type: clinical trials